CK-MB Rapid Test – Quantitative CK-MB Measurement
Quantitative CK-MB rapid test for measuring cardiac-specific creatine kinase in serum, plasma and whole blood using the BIOspeed analyzer.
CK-MB Rapid Test Kit for Quantitative CK-MB Measurement
The CK-MB Rapid Test Kit enables quantitative measurement of cardiac-specific creatine kinase (CK-MB) in serum, plasma and whole blood. CK-MB is a cardiac marker that provides important diagnostic information in the assessment of acute myocardial infarction.
For quantitative CK-MB measurement, the rapid test kit can be used with BIOspeed Single or BIOspeed Multi. After an incubation time of 15 minutes, the test cassette is evaluated using the BIOspeed analyzer.
What Is CK-MB?
Creatine kinase (CK) is an enzyme found in different tissues throughout the human body. CK-MB is an isoenzyme of creatine kinase with particular relevance in cardiac diagnostics.
When muscle cells are damaged, creatine kinase can be released into the bloodstream. Measurement of cardiac-specific CK-MB enables its concentration to be determined quantitatively and considered as a laboratory parameter in the assessment of possible cardiac changes.
A CK-MB result is not interpreted in isolation. Diagnostic assessment also takes into account other cardiac markers, including total CK, as well as the available clinical and laboratory findings.
What Is the Significance of CK-MB in Acute Myocardial Infarction?
CK-MB can be used as a diagnostic marker in the assessment of acute myocardial infarction. Damage to myocardial tissue can be associated with changes in the CK-MB concentration in the blood, providing additional information for diagnostic assessment.
Quantitative measurement provides a numerical CK-MB result that can be evaluated together with the patient's clinical situation, other cardiac markers and additional laboratory findings.
Particularly in cardiac diagnostics, the combination of different sources of diagnostic information is important. A single CK-MB result should therefore not be regarded as a confirmed diagnosis on its own.
Why Is the Time Course of CK-MB Relevant?
Following myocardial infarction, the CK-MB concentration in the blood can increase after a delay. After reaching its peak, the concentration subsequently decreases and can return to the normal range within a few days.
When interpreting a quantitative CK-MB result, the timing of the measurement in relation to the clinical event is therefore relevant in addition to the measured concentration.
This time-dependent pattern is an important aspect when considering CK-MB as a cardiac marker and complements the assessment of other laboratory parameters and clinical findings.
Benefits of the CK-MB Rapid Test Kit
- Quantitative measurement of cardiac-specific creatine kinase (CK-MB)
- Results after 15 minutes
- Suitable for serum, plasma and whole blood
- Timely CK-MB measurement directly at the point of care
- Evaluation with the BIOspeed analyzer
- Compatible with BIOspeed Single and BIOspeed Multi
- Test- and lot-specific information provided via the included ID chip
Quantitative CK-MB Measurement Using Fluorescence Immunoassay
The CK-MB Rapid Test Kit uses a fluorescence immunochromatographic assay for quantitative measurement of CK-MB. Specific antibodies enable the detection of cardiac-specific creatine kinase and generate a measurable fluorescence signal whose intensity correlates with the CK-MB concentration in the sample.
After incubation, the test cassette is evaluated using the BIOspeed analyzer. The lot-specific calibration curve is stored on the corresponding ID chip. Based on the measured test signal and the stored calibration data, the analyzer determines the quantitative CK-MB concentration.
Performance Characteristics of the CK-MB Rapid Test Kit
Parameter: Cardiac-specific creatine kinase (CK-MB)
Determination: Quantitative
Sample material: Serum, plasma or whole blood
Sample volume: 75 µL
Test principle: Fluorescence immunochromatographic assay
Evaluation: BIOspeed Single or BIOspeed Multi
Incubation time: 15 minutes
Kit contents: 25 test cassettes, sample dilution buffer, 25 pipette tips and 1 ID chip
CK-MB in the Context of Other Cardiac Markers
Within the BIOspeed test portfolio, CK-MB belongs to the group of cardiac markers. Depending on the diagnostic question, different laboratory parameters can provide distinct and complementary information for clinical assessment.
In addition to CK-MB, quantitative rapid tests for cTnI, NT-proBNP, myoglobin and D-dimer are available for the BIOspeed analyzer system. The individual parameters provide information on different diagnostic aspects and can be selected according to the respective clinical question. BIOMED also currently lists all five parameters together as cardiac markers within the BIOspeed portfolio.
This allows different quantitative tests in the field of cardiac diagnostics to be performed using the same BIOspeed analyzer system.
CK-MB Rapid Test for Point-of-Care Cardiac Diagnostics
The CK-MB Rapid Test Kit enables quantitative measurement of a cardiac marker using the BIOspeed analyzer system. Serum, plasma and whole blood can be used as sample materials, supporting integration into different diagnostic workflows.
With an incubation time of 15 minutes, the quantitative result is available promptly. The CK-MB Rapid Test is therefore suitable for healthcare facilities requiring quantitative measurement of cardiac-specific creatine kinase directly at the point of care.
For further quantitative rapid tests and compatible analyzers, visit our BIOspeed Analyzers and Rapid Test Kits category.
| Parameter | CK-MB |
|---|---|
| Packaging unit | 25 test cassettes, 25 pipette tips, 1 ID chip, sample dilution buffer |